Dr. Michael Stein, Chairman and CEO of OxStem Ltd., the award-winning bio-technology spin-out from the University of Oxford, is a serial entrepreneur, medical scientist, business executive, and strategic advisor with senior experience in healthcare, media and software industries. He is highly skilled in business development at the top levels of government and corporate enterprise. In 2001, he co-founded the Map of Medicine Ltd (the Map) with University College London. The Map was nationally licensed across NHS England (2005-15) and is now primarily used by commissioners for planning healthcare services across the continuum of care in the NHS and other countries. The Map was acquired by Hearst Business Media (HBM) in 2008, and Michael transitioned as executive vice-president (healthcare innovation) to HBM until 2011. Since 2011, Michael has assisted a number of start-up businesses, notably serving as the founding CEO for Doctor Care Anywhere, acquired by Synergix in 2015. Michael graduated as a medical doctor (Honours) and biochemist (First Class Honours) from the University of Cape Town (1988) and from the University of Oxford (Rhodes Scholar) with a doctorate in Physiological Sciences (Immunology). He subsequently was appointed as a Junior Research Fellow in Medicine at Trinity College, Oxford (1992-95). Dr. Michael Stein, Chairman and CEO of OxStem Ltd., the award-winning bio-technology spin-out from the University of Oxford, is a serial entrepreneur, medical scientist, business executive, and strategic advisor with senior experience in healthcare, media and software industries. He is highly skilled in business development at the top levels of government and corporate enterprise. In 2001, he co-founded the Map of Medicine Ltd (the Map) with University College London. The Map was nationally licensed across NHS England (2005-15) and is now primarily used by commissioners for planning healthcare services across the continuum of care in the NHS and other countries. The Map was acquired by Hearst Business Media (HBM) in 2008, and Michael transitioned as executive vice-president (healthcare innovation) to HBM until 2011. Since 2011, Michael has assisted a number of start-up businesses, notably serving as the founding CEO for Doctor Care Anywhere, acquired by Synergix in 2015. Michael graduated as a medical doctor (Honours) and biochemist (First Class Honours) from the University of Cape Town (1988) and from the University of Oxford (Rhodes Scholar) with a doctorate in Physiological Sciences (Immunology). He subsequently was appointed as a Junior Research Fellow in Medicine at Trinity College, Oxford (1992-95).

Preclinical development